Search Results - "Walshaw, Martin J"

Refine Results
  1. 1

    Use of Dynamic Chest Radiography to Assess Treatment of Pulmonary Exacerbations in Cystic Fibrosis by FitzMaurice, Thomas Simon, McCann, Caroline, Nazareth, Dilip S, McNamara, Paul S, Walshaw, Martin J

    Published in Radiology (01-06-2022)
    “…Background Although spirometry is an important marker in the management of pulmonary exacerbations in cystic fibrosis (CF), it is a forced maneuver and can…”
    Get full text
    Journal Article
  2. 2

    Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis by Shelley, James, Dawson, Ellen A, Boddy, Lynne M, Stewart, Claire E, Frost, Freddy, Nazareth, Dilip, Walshaw, Martin J, Knowles, Zoe R

    Published in PloS one (01-08-2022)
    “…There are few examples of interventions designed to promote physical activity (PA) in adults with Cystic fibrosis (CF). Increasing levels of habitual PA may be…”
    Get full text
    Journal Article
  3. 3

    Dynamic chest radiography: a state-of-the-art review by Fyles, Fred, FitzMaurice, Thomas S., Robinson, Ryan E., Bedi, Ram, Burhan, Hassan, Walshaw, Martin J.

    Published in Insights into imaging (19-06-2023)
    “…Dynamic chest radiography (DCR) is a real-time sequential high-resolution digital X-ray imaging system of the thorax in motion over the respiratory cycle,…”
    Get full text
    Journal Article
  4. 4

    Characterisation of hemidiaphragm dysfunction using dynamic chest radiography: a pilot study by FitzMaurice, Thomas Simon, McCann, Caroline, Nazareth, Dilip S, Walshaw, Martin J

    Published in ERJ open research (01-01-2022)
    “…Dynamic chest radiography (DCR) is a novel real-time digital fluoroscopic imaging system that produces clear, wide field-of-view diagnostic images of the…”
    Get full text
    Journal Article
  5. 5

    Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis by Ashish, Abdul, Paterson, Steve, Mowat, Eilidh, Fothergill, Joanne L, Walshaw, Martin J, Winstanley, Craig

    Published in Journal of cystic fibrosis (01-12-2013)
    “…Abstract Background Populations of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa undergo extensive diversification in the cystic fibrosis (CF)…”
    Get full text
    Journal Article
  6. 6

    Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain by Fothergill, Joanne L, Panagea, Stavroula, Hart, Charles A, Walshaw, Martin J, Pitt, Tyrone L, Winstanley, Craig

    Published in BMC microbiology (23-05-2007)
    “…Some isolates of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa exhibit an unusual virulence-related phenotype, characterized by…”
    Get full text
    Journal Article
  7. 7

    Effect of Antibiotic Treatment on Bacteriophage Production by a Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa by FOTHERGILL, Joanne L, MOWAT, Eilidh, WALSHAW, Martin J, LEDSON, Martin J, JAMES, Chloe E, WINSTANLEY, Craig

    Published in Antimicrobial Agents and Chemotherapy (01-01-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  8. 8

    A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance by SALUNKHE, Prabhakar, SMART, Catherine H. M, ALUN, J, MORGAN, W, PANAGEA, Stavroula, WALSHAW, Martin J, HART, C. Anthony, GEFFERS, Robert, TÜMMLER, Burkhard, WINSTANLEY, Craig

    Published in Journal of Bacteriology (01-07-2005)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  9. 9

    A Subtype of a Pseudomonas aeruginosa Cystic Fibrosis Epidemic Strain Exhibits Enhanced Virulence in a Murine Model of Acute Respiratory Infection by Carter, Melissa E. K., Fothergill, Joanne L., Walshaw, Martin J., Rajakumar, Kumar, Kadioglu, Aras, Winstanley, Craig

    Published in The Journal of infectious diseases (15-09-2010)
    “…Background. The Liverpool epidemic strain (LES) of Pseudomonas aeruginosa is a particularly successful cystic fibrosis (CF) pathogen associated with…”
    Get full text
    Journal Article
  10. 10

    Impact of Pseudomonas aeruginosa Genomic Instability on the Application of Typing Methods for Chronic Cystic Fibrosis Infections by Fothergill, Joanne L, White, Judith, Foweraker, Juliet E, Walshaw, Martin J, Ledson, Martin J, Mahenthiralingam, Eshwar, Winstanley, Craig

    Published in Journal of Clinical Microbiology (01-06-2010)
    “…The Liverpool epidemic strain (LES) of Pseudomonas aeruginosa is widespread among cystic fibrosis (CF) patients in the United Kingdom and has emerged recently…”
    Get full text
    Journal Article
  11. 11

    Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections by FOTHERGILL, Joanne L, WALSHAW, Martin J, WINSTANLEY, Craig

    Published in The European respiratory journal (01-07-2012)
    “…Pseudomonas aeruginosa chronic lung infections are the major cause of morbidity and mortality associated with cystic fibrosis. For many years, the consensus…”
    Get full text
    Journal Article
  12. 12

    Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes by Frost, Freddy, Dyce, Paula, Nazareth, Dilip, Malone, Victoria, Walshaw, Martin J.

    Published in Journal of cystic fibrosis (01-11-2018)
    “…Continuous glucose monitoring (CGM) allows assessment of day to day glycaemic excursions and detects early glucose handling abnormalities that may not be…”
    Get full text
    Journal Article
  13. 13

    Cystic fibrosis: Diagnosis and management – NICE guideline 78 by Walshaw, Martin J.

    Published in Paediatric respiratory reviews (01-08-2019)
    “…NICE produced a guideline for the diagnosis and management of CF (NG78) in October 2017. This paper describes the process of producing the guideline and…”
    Get full text
    Journal Article
  14. 14

    Ivacaftor Is Associated with Reduced Lung Infection by Key Cystic Fibrosis Pathogens. A Cohort Study Using National Registry Data by Frost, Freddy J, Nazareth, Dilip S, Charman, Susan C, Winstanley, Craig, Walshaw, Martin J

    Published in Annals of the American Thoracic Society (01-11-2019)
    “…Ivacaftor can greatly improve clinical outcomes in people with cystic fibrosis (CF) and has been shown to have antibacterial properties, yet the long-term…”
    Get full text
    Journal Article
  15. 15

    Divergent, coexisting Pseudomonas aeruginosa lineages in chronic cystic fibrosis lung infections by Williams, David, Evans, Benjamin, Haldenby, Sam, Walshaw, Martin J, Brockhurst, Michael A, Winstanley, Craig, Paterson, Steve

    “…Pseudomonas aeruginosa, the predominant cause of chronic airway infections of patients with cystic fibrosis, exhibits extensive phenotypic diversity among…”
    Get full text
    Journal Article
  16. 16

    Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections by MOWAT, Eilidh, PATERSON, Steve, FOTHERGILL, Joanne L, WRIGHT, Elli A, LEDSON, Martin J, WALSHAW, Martin J, BROCKHURST, Michael A, WINSTANLEY, Craig

    “…Pseudomonas aeruginosa isolates from chronic cystic fibrosis lung infections display multiple phenotypes indicating extensive population diversity. We aimed to…”
    Get full text
    Journal Article
  17. 17

    Prevalence, risk factors and outcomes of cardiac disease in cystic fibrosis: a multinational retrospective cohort study by Frost, Freddy, Nazareth, Dilip, Fauchier, Laurent, Wat, Dennis, Shelley, James, Austin, Philip, Walshaw, Martin J, Lip, Gregory Y H

    Published in The European respiratory journal (01-10-2023)
    “…Although people living with cystic fibrosis (PwCF) often have some risk factors for cardiovascular disease, including diabetes and chronic inflammation, little…”
    Get more information
    Journal Article
  18. 18

    Pseudomonas aeruginosa adaptation and diversification in the non-cystic fibrosis bronchiectasis lung by Hilliam, Yasmin, Moore, Matthew P, Lamont, Iain L, Bilton, Diana, Haworth, Charles S, Foweraker, Juliet, Walshaw, Martin J, Williams, David, Fothergill, Joanne L, De Soyza, Anthony, Winstanley, Craig

    Published in The European respiratory journal (01-04-2017)
    “…To characterise populations during chronic lung infections of non-cystic fibrosis bronchiectasis patients, we used whole-genome sequencing to 1) assess the…”
    Get full text
    Journal Article
  19. 19

    Measuring the effect of elexacaftor/tezacaftor/ivacaftor combination therapy on the respiratory pump in people with CF using dynamic chest radiography by FitzMaurice, Thomas S, McCann, Caroline, Nazareth, Dilip, Shaw, Matthew, McNamara, Paul S, Walshaw, Martin J

    Published in Journal of cystic fibrosis (01-11-2022)
    “…•New, sensitive markers of lung health are needed in the era of CFTR modulators•Dynamic chest radiography (DCR) gives high resolution images of the thorax in…”
    Get full text
    Journal Article
  20. 20

    Between a Rock and an Airspace: Pneumothorax After Extracorporeal Shock Wave Lithotripsy for Renal Stones in a Patient With Cystic Fibrosis by Frost, Freddy, Griffiths, Paul, Brockelsby, Chris, Lynch, Ciaran, Walshaw, Martin J, Nazareth, Dilip

    Published in Chest (01-09-2018)
    “…Renal disease is a well-recognized manifestation of cystic fibrosis (CF) and people with CF are at increased risk of nephrolithiasis. Lithotripsy is the…”
    Get full text
    Journal Article